|
ABUS Arbutus Biopharma Corp 1447028 |
| Balance Sheet |
|
Current Assets
|
$273,883,000.00 |
|
Assets
|
$274,025,000.00 |
|
Current Liabilities
|
$3,364,000.00 |
|
Liabilities
|
$15,292,000.00 |
|
Equity
|
$258,733,000.00 |
|
Shares Out
|
197634118.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-14,128,000.00 |
|
Investing Cash Flow
|
$538,000.00 |
| Market Analysis |
Market Cap
|
$942,714,742.86 |
|
Price
|
$4.77 |
|
BVPS
|
1.31 |
|
PB
|
3.64 |
|
EPS
|
-0.03 |
|
PE
|
5.57 |
|
PS
|
232.42 |
|
FCF
|
$-14,128,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:36 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:26 |
|
| Apr |
May |
Jun |
| 2026-03-23 |
-0.17 |
|
|
2026-05-13 |
0.87 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.01 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ABUS documents filed with the SEC.
ABUS Filings
Clear
